We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
- Authors
Hankey, B F; Feuer, E J; Clegg, L X; Hayes, R B; Legler, J M; Prorok, P C; Ries, L A; Merrill, R M; Kaplan, R S
- Abstract
The prostate-specific antigen test was approved by the U.S. Food and Drug Administration in 1986 to monitor the disease status in patients with prostate cancer and, in 1994, to aid in prostate cancer detection. However, after 1986, the test was performed on many men who had not been previously diagnosed with prostate cancer, apparently resulting in the diagnosis of a substantial number of early tumors. Our purpose is to provide insight into the effect of screening on prostate cancer rates. Detailed data are presented for whites because the size of the population allows for calculating statistically reliable rates; however, similar overall trends are seen for African-Americans and other races.
- Publication
Journal of the National Cancer Institute, 1999, Vol 91, Issue 12, p1017
- ISSN
0027-8874
- Publication type
Journal Article
- DOI
10.1093/jnci/91.12.1017